L. Dogliotti Et Al. , "Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: Results of a randomized phase 2 trial," EUROPEAN UROLOGY , vol.52, no.1, pp.134-141, 2007
Dogliotti, L. Et Al. 2007. Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: Results of a randomized phase 2 trial. EUROPEAN UROLOGY , vol.52, no.1 , 134-141.
Dogliotti, L., Carteni, G., Siena, S., Bertetto, O., Martoni, A., Bono, A., ... Amadori, D.(2007). Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: Results of a randomized phase 2 trial. EUROPEAN UROLOGY , vol.52, no.1, 134-141.
Dogliotti, Luigi Et Al. "Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: Results of a randomized phase 2 trial," EUROPEAN UROLOGY , vol.52, no.1, 134-141, 2007
Dogliotti, Luigi Et Al. "Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: Results of a randomized phase 2 trial." EUROPEAN UROLOGY , vol.52, no.1, pp.134-141, 2007
Dogliotti, L. Et Al. (2007) . "Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: Results of a randomized phase 2 trial." EUROPEAN UROLOGY , vol.52, no.1, pp.134-141.
@article{article, author={Luigi Dogliotti Et Al. }, title={Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: Results of a randomized phase 2 trial}, journal={EUROPEAN UROLOGY}, year=2007, pages={134-141} }